Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary W Jay

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|November 3, 2011
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjectsGai Ling Li, Helen Winter, Rosalin Arends, et al.
Toxicologic Pathology|December 2, 2010
Animal models for neural diseasesGary W Jay, Ronald B Demattos, Edward J Weinstein, et al.
Pain|August 19, 2008
Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical TrialsDennis C Turk, Robert H Dworkin, Michael P McDermott, et al.
Pain|December 20, 2015
Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendationsStephen A Cooper, Paul J Desjardins, Dennis C Turk, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 29, 2014
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|March 9, 2010
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|November 3, 2011
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjectsGai Ling Li, Helen Winter, Rosalin Arends, et al.
Toxicologic Pathology|December 2, 2010
Animal models for neural diseasesGary W Jay, Ronald B Demattos, Edward J Weinstein, et al.
Pain|August 19, 2008
Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical TrialsDennis C Turk, Robert H Dworkin, Michael P McDermott, et al.
Pain|December 20, 2015
Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendationsStephen A Cooper, Paul J Desjardins, Dennis C Turk, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|May 29, 2014
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain|March 9, 2010
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pageof 3